Even as the Covid wave in Florida continues, Gov. Ron DeSantis’ administration is once again advising against the mRNA ...

Vaccines for the Fall and Winter 2024–2025 season are now available. Generally, experts recommend COVID-19 and flu vaccines ...

Updated COVID-19 vaccines are now available, but uninsured individuals may have to pay $200. Learn where to find free or ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending.

Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...

Stephane Bancel, Moderna CEO, joins 'Squawk Box' to discuss Moderna's recent stock performance, what could explain the ...

Moderna, Inc. slashed its R&D budget by $1.1 billion for 2027 and cut 2025 sales targets, indicating financial struggles post ...

Moderna is aiming to reduce its research and development budget by about 20pc over the next three years, as the company tries ...